Natural killer cell functional defects in pediatric patients with severe and recurrent herpesvirus infections

Journal of Infectious Diseases

Volumn 207, Issue 3, 2013, Pages 458-468

  Ornstein, Bradley W ^a   Hill, Elaise B ^a   Geurs, Theresa L ^a   French, Anthony R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD11b; Herpesvirus; IL 2; NK cells; pediatric

Indexed keywords

CD11B ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; GRANZYME A; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 18 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR ALPHA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; PROTEIN ILT 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DEGRANULATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE ACTIVATION; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL FUNCTIONAL DEFICIT; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT INFECTION; SCHOOL CHILD; UPREGULATION; VIRUS REACTIVATION; CYTOTOXICITY; ENZYME ACTIVATION; RECURRENT DISEASE;

ADOLESCENT; ADULT; CELL LINE; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GRANZYMES; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNOPHENOTYPING; INFANT; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, NATURAL KILLER CELL; YOUNG ADULT;

EID: 84872039755     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis701     Document Type: Article

References (50)

1. Cunningham AL, Diefenbach RJ, Miranda-Saksena M, et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis 2006; 194 (Suppl 1):S11-8.
2. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186 (Suppl 1):S3-28.
3. Mossman KL, Ashkar AA. Herpesviruses and the innate immune response. Viral Immunol 2005; 18:267-81.
4. Jonjic S, Babic M, Polic B, Krmpotic A. Immune evasion of natural killer cells by viruses. Curr Opin Immunol 2008; 20:30-8.
5. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 2008; 8:259-68.
6. Brandstadter JD, Yang Y. Natural killer cell responses to viral infection. J Innate Immun 2011; 3:274-9.
7. Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006; 214:73-91.
8. Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331:44-9.
9. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-40.
10. Fehniger TA, Cooper MA, Nuovo GJ, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cellderived IL-2: a potential new link between adaptive and innate immunity. Blood 2003; 101:3052-7.
11. Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 2002; 4:1545-58.
12. Orange JS. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol 2006; 6:399-409.
13. Jawahar S, Moody C, Chan M, Finberg R, Geha R, Chatila T. Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II). Clin Exp Immunol 1996; 103:408-13.
14. de Vries E, Koene HR, Vossen JM, et al. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. Blood 1996; 88:3022-7.
15. Aoukaty A, Lee IF, Wu J, Tan R. Chronic active Epstein-Barr virus infection associated with low expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on natural killer cells. J Clin Immunol 2003; 23:141-5.
16. Gazit R, Garty BZ, Monselise Y, et al. Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 2004; 103:1965-6.
17. Neron S, Thibault L, Dussault N, et al. Characterization of mononuclear cells remaining in the leukoreduction system chambers of apheresis instruments after routine platelet collection: a new source of viable human blood cells. Transfusion 2007; 47:1042-9.
18. Carter C, Savic S, Cole J, Wood P. Natural killer cell receptor expression in patients with severe and recurrent Herpes simplex virus-1 (HSV-1) infections. Cell Immunol 2007; 246:65-74.
19. Fujisaki H, Kakuda H, Shimasaki N, et al. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. Cancer Res 2009; 69:4010-7.
20. Brehm C, Huenecke S, Quaiser A, et al. IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study. PLoS One 2011; 6:e27351.
21. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9:503-10.
22. Lanier LL, Buck DW, Rhodes L, et al. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 1988; 167:1572-85.
23. Craston R, Koh M, Mc Dermott A, Ray N, Prentice HG, Lowdell MW. Temporal dynamics of CD69 expression on lymphoid cells. J Immunol Methods 1997; 209:37-45.
24. Caligiuri MA. Human natural killer cells. Blood 2008; 112:461-9.
25. Zhang SY, Boisson-Dupuis S, Chapgier A, et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol Rev 2008; 226:29-40.
26. Kim S, Iizuka K, Kang HS, et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002; 3:523-8.
27. Ross GD, Vetvicka V. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin Exp Immunol 1993; 92:181-4.
28. Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006; 314:308-12.
29. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317:1522-7.
30. Guo Y, Audry M, Ciancanelli M, et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med 2011; 208:2083-98.
31. Sancho-Shimizu V, Perez de Diego R, Lorenzo L, et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest 2011; 121:4889-902.
32. Bihl F, Germain C, Luci C, Braud VM. Mechanisms of NK cell activation: CD4(+) T cells enter the scene. Cell Mol Life Sci 2011; 68:3457-67.
33. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 2001; 31:2680-9.
34. Chisholm SE, Howard K, Gomez MV, Reyburn HT. Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors. J Infect Dis 2007; 195:1160-8.
35. Monsivais-Urenda A, Noyola-Cherpitel D, Hernandez-Salinas A, et al. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol 2010; 40:1418-27.
36. Beziat V, Dalgard O, Asselah T, et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol 2012; 42:447-57.
37. Lopez-Verges S, Milush JM, Schwartz BS, et al. Expansion of a unique CD57NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci USA 2011; 108: 14725-32.
38. Bjorkstrom NK, Lindgren T, Stoltz M, et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 2011; 208:13-21.
39. Petitdemange C, Becquart P, Wauquier N, et al. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog 2011; 7:e1002268.
40. Kohl S, Loo LS, Schmalstieg FS, Anderson DC. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150, 95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo. J Immunol 1986; 137:1688-94.
41. Dinauer MC. Disorders of neutrophil function: an overview. Methods Mol Biol 2007; 412:489-504.
42. Lima M, Almeida J, Montero AG, et al. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis. Am J Pathol 2004; 165:1117-27.
43. Orange JS, Chehimi J, Ghavimi D, Campbell D, Sullivan KE. Decreased natural killer (NK) cell function in chronic NK cell lymphocytosis associated with decreased surface expression of CD11b. Clin Immunol 2001; 99:53-64.
44. French AR, Kim S, Fehniger TA, et al. Chronic lymphocytosis of functionally immature natural killer cells. J Allergy Clin Immunol 2007; 120:924-31.
45. Crozat K, Eidenschenk C, Jaeger BN, et al. Impact of beta2 integrin deficiency on mouse natural killer cell development and function. Blood 2011; 117:2874-82.
46. Cooper MA, Bush JE, Fehniger TA, et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 2002; 100:3633-8.
47. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Muller W, Di Santo JP. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 2003; 101:4887-93.
48. Vales-Gomez M, Shiroishi M, Maenaka K, Reyburn HT. Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2. J Virol 2005; 79:2251-60.
49. Colonna M, Navarro F, Bellon T, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997; 186:1809-18.
50. Scott-Algara D, Arnold V, Didier C, et al. The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells. PLoS One 2008; 3:e1975.